Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia
Clinical trial NCT00045695 · COMPLETED
Trial details
- NCT number
- NCT00045695
- Sponsor
- NCIC Clinical Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-08-01
- Primary completion
- 2006-03-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.